RIFAMPIN
Inquiry
| Post Date: | Mar 12,2022 |
| Expiry Date: | Sep 08,2022 |
| Detailed Description: | Cas No. :13292-46-1 |
| CAS Registry Number: | 13292-46-1 |
| Synonyms: | ;3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;R/AMP;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV Sodium;Rifandin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; |
| Molecular Formula: | C43H58N4O12 |
| Molecular Weight: | 822.9402 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xn:Harmful; |
| Risk Codes: | R22:; R36/37/38:; |
| Safety Description: | S26:; S36:; |
| Company: | ORICHEM INTERNATIONAL LTD. [ China ] |
| Contact: | Jension jin |
| Tel: | 86-571-85270505 |
| Fax: | 86-571-85270303 |
| Email: | jension@orichem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
